4Bellomo R, Ronco C, Kellum JA, et al. Acute renal failuredefinition, outcome measures, animal models, fluid therapy and information technology needs, the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care, 2004, 8:R204-212.
5Ostermann M, Alvarez G, Sharpe MD, et al. Frusemide administration in critically ill patients by continuous compared to bolus therapy. Nephron Clin Pract, 2007,107:c70-76.
6Mancano MA. ISMP Adverse Drug Reacfions-Furosemide-lnduced Immune Thrombocytopenia; Type I Interferon-Induced Ischemic Colitis; Dronedarone-Associated Acute Renal Failure; Modafinil-In- duced Psychosis [J]. Hospital Pharmacy, 2013, 48(11): 901-904.
7Dussol B, Mouss-Frances J, Morange S, et al. A pilot study compar- ing furosemide and hydrochlorothiazide in patients with hyperten- sion and stage 4 or 5 chronic kidney disease [J]. The Journal of Clin- ical Hypertension, 2012, 14(1): 32-37.
8Bagshaw SM, Gibney RT, McAlister FA, et al. The SPARK Study: a phase II randomized blinded controlled trial of the effect of furose- mide in critically ill patients with early acute kidney injury [J]. Tri- als, 2010, 11(1): 50.
9Peters MN, Alkadri ME, Katz MJ, et al. Effect of Low Dose Dopa- mine Infusion On Renal Function in Acute Decompensated Heart Failure Patients Treated with Intravenous Furosemide [C]//Southem Regional Meeting of the search, 2013, 61(2): 373-373.
10Lcmcs HP, Amujo S, Nascimento D, et al. Use of small doses of furosemide in chronic kidney disease patients with residual renal func- tion undergoing hemodialysis [J]. Clinical and Experimental Ne- phrology, 2011, 15(4): 554-559.
